Developmental Medicine and Child Neurology 2014-02-01

Status dystonicus: a practice guide.

Nicholas M Allen, Jean-Pierre Lin, Tim Lynch, Mary D King

Index: Dev. Med. Child Neurol. 56(2) , 105-12, (2014)

Full Text: HTML

Abstract

Status dystonicus is a rare, but life-threatening movement disorder emergency. Urgent assessment is required and management is tailored to patient characteristics and complications. The use of dystonia action plans and early recognition of worsening dystonia may potentially facilitate intervention or prevent progression to status dystonicus. However, for established status dystonicus, rapidly deployed temporizing measures and different depths of sedation in an intensive care unit or high dependency unit are the most immediate and effective modalities for abating life-threatening spasms, while dystonia-specific treatment takes effect. If refractory status dystonicus persists despite orally active anti-dystonia drugs and unsuccessful weaning from sedative or anaesthetic agents, early consideration of intrathecal baclofen or deep brain stimulation is required. During status dystonicus, precise documentation of dystonia sites and severity as well as the baseline clinical state, using rating scales and videos is recommended. Further published descriptions of the clinical nature, timing of evolution, resolution, and epidemiology of status dystonicus are essential for a better collective understanding of this poorly understood heterogeneous emergency. In this review, we provide an overview of the clinical presentation and suggest a management approach for status dystonicus. © 2013 Mac Keith Press.


Related Compounds

  • Chloral hydrate
  • Baclofen
  • Clonidine

Related Articles:

The matrix polysaccharide (1;3,1;4)-β-D-glucan is involved in silicon-dependent strengthening of rice cell wall.

2015-02-01

[Plant Cell Physiol. 56(2) , 268-76, (2015)]

Appetitive cue-evoked ERK signaling in the nucleus accumbens requires NMDA and D1 dopamine receptor activation and regulates CREB phosphorylation.

2014-11-01

[Learn. Mem. 21(11) , 606-15, (2014)]

Ciliary abnormalities in senescent human fibroblasts impair proliferative capacity.

2014-01-01

[Cell Cycle 13(17) , 2773-9, (2014)]

The CRE1 cytokinin pathway is differentially recruited depending on Medicago truncatula root environments and negatively regulates resistance to a pathogen.

2015-01-01

[PLoS ONE 10(1) , e0116819, (2015)]

bFGF attenuates endoplasmic reticulum stress and mitochondrial injury on myocardial ischaemia/reperfusion via activation of PI3K/Akt/ERK1/2 pathway.

2015-03-01

[J. Cell. Mol. Med. 19(3) , 595-607, (2015)]

More Articles...